William R. Miller, MD

Assistant Professor of Medicine, Academic Institute
Assistant Clinical Member, Research Institute
Houston Methodist


Publications

Comparison of cefiderocol in-vitro susceptibility testing modalities
Teran, NS, Vuong, L, Phe, K, Lasco, TM, Miller, WR & Tam, VH 2024, , Journal of Global Antimicrobial Resistance, vol. 37, pp. 100-101. https://doi.org/10.1016/j.jgar.2024.03.011

Differential in vitro susceptibility to ampicillin/ceftriaxone combination therapy among Enterococcus faecalis infective endocarditis clinical isolates
Westbrook, KJ, Chilambi, GS, Stellfox, ME, Nordstrom, HR, Li, Y, Iovleva, A, Shah, NH, Jones, CE, Kline, EG, Squires, KM, Miller, WR, Tran, TT, Arias, CA, Doi, Y, Shields, RK & Tyne, DV 2024, , Journal of Antimicrobial Chemotherapy, vol. 79, no. 4, pp. 801-809. https://doi.org/10.1093/jac/dkae032

LiaX is a surrogate marker for cell envelope stress and daptomycin non-susceptibility in Enterococcus faecium
Axell-House, DB, Simar, SR, Panesso, D, Rincon, S, Miller, WR, Khan, A, Pemberton, OA, Valdez, L, Nguyen, AH, Hood, KS, Rydell, K, DeTranaltes, AM, Jones, MN, Atterstrom, R, Reyes, J, Sahasrabhojane, PV, Suleyman, G, Zervos, M, Shelburne, S, Singh, KV, Shamoo, Y, Hanson, BM, Tran, TT & Arias, CA 2024, , Antimicrobial Agents and Chemotherapy, vol. 68, no. 3. https://doi.org/10.1128/aac.01069-23

Cefiderocol heteroresistance associated with mutations in TonB-dependent receptor genes in Pseudomonas aeruginosa of clinical origin.
Egge, SL, Rizvi, SA, Simar, SR, Alcalde, M, Martinez, JRW, Hanson, BM, Dinh, AQ, Baptista, RP, Tran, TT, Shelburne, SA, Munita, JM, Arias, CA, Hakki, M & Miller, WR 2024, , bioRxiv. https://doi.org/10.1101/2024.01.30.578008

LiaX is a surrogate marker for cell envelope stress and daptomycin non-susceptibility in Enterococcus faecium
Axell-House, DB, Simar, SR, Panesso, D, Rincon, S, Miller, WR, Khan, A, Pemberton, OA, Valdez, L, Nguyen, AH, Hood, KS, Rydell, K, DeTranaltes, AM, Jones, MN, Atterstrom, R, Reyes, J, Sahasrabhojane, PV, Suleyman, G, Zervos, M, Shelburne, S, Singh, KV, Shamoo, Y, Hanson, BM, Tran, TT & Arias, CA 2024, , Antimicrobial Agents and Chemotherapy, vol. 68, no. 3. https://doi.org/10.1128/aac.01069-23

The emergence of cefiderocol resistance in Pseudomonas aeruginosa from a heteroresistant isolate during prolonged therapy
Teran, N, Egge, SL, Phe, K, Baptista, RP, Tam, VH & Miller, WR 2024, , Antimicrobial Agents and Chemotherapy, vol. 68, no. 1. https://doi.org/10.1128/aac.01009-23

The emergence of cefiderocol resistance in Pseudomonas aeruginosa from a heteroresistant isolate during prolonged therapy.
Teran, N, Egge, SL, Phe, K, Baptista, RP, Tam, VH & Miller, WR 2024, , Antimicrobial Agents and Chemotherapy, vol. 68, no. 1, pp. e0100923. https://doi.org/10.1128/aac.01009-23

Membrane Lipids Augment Cell Envelope Stress Signaling and Resistance to Antibiotics and Antimicrobial Peptides in Enterococcus faecalis
Miller, WR, Nguyen, A, Singh, KV, Rizvi, S, Khan, A, Erickson, SG, Egge, S, Cruz, MR, Dinh, A, Diaz, L, Zhang, R, Xu, L, Garsin, DA, Shamoo, Y & Arias, CA 2023, , bioRxiv, pp. 1 - 30. <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10614854/>

High-level ceftazidime/avibactam resistance in Escherichia coli conferred by the novel plasmid-mediated ß-lactamase CMY-185 variant
Shropshire, WC, Endres, BT, Borjan, J, Aitken, SL, Bachman, WC, Mcelheny, CL, Wu, CT, Egge, SL, Khan, A, Miller, WR, Bhatti, MM, Saharasbhojane, P, Kawai, A, Shields, RK, Shelburne, SA & Doi, Y 2023, , Journal of Antimicrobial Chemotherapy, vol. 78, no. 10, pp. 2442-2450. https://doi.org/10.1093/jac/dkad249

The response of mpox-associated inflammatory syndrome to steroid therapy
Arias, CA, Miller, WR, Olsen, RJ, Gollihar, J & Armstrong, A 2023, , The Lancet Infectious Diseases, vol. 23, no. 8, pp. e323-e324. https://doi.org/10.1016/S1473-3099(22)00876-3

Evolving landscape of carbapenem-resistant Pseudomonas aeruginosa at a single centre in the USA
Sakurai, A, Dinh, AQ, Hanson, BM, Shropshire, WC, Rizvi, SA, Rydell, K, Tran, TT, Wanger, A, Arias, CA & Miller, WR 2023, , JAC-Antimicrobial Resistance, vol. 5, no. 3, dlad070, pp. dlad070. https://doi.org/10.1093/jacamr/dlad070

Clinical characteristics, microbiology and outcomes of a cohort of patients treated with ceftolozane/tazobactam in acute care inpatient facilities, Houston, Texas, USA
Tran, TT, Cabrera, NL, Gonzales-Luna, AJ, Carlson, TJ, Alnezary, F, Miller, WR, Sakurai, A, Dinh, AQ, Rydell, K, Rios, R, Diaz, L, Hanson, BM, Munita, JM, Pedroza, C, Shelburne, SA, Aitken, SL, Garey, KW, Dillon, R, Puzniak, L & Arias, CA 2023, , JAC-Antimicrobial Resistance, vol. 5, no. 1, dlac131, pp. dlac131. https://doi.org/10.1093/jacamr/dlac131

Evaluation of Cefazolin High Inoculum Effect in Methicillin-Susceptible Staphylococcus aureus (MSSA) Using Gold standard MICs and Rapid Colorimetric Test (RCT)
Malikazad, H, Rizvi, S, Venugopalan, V, Santevechi, B, Panesso, D, Singh, KV, Gomez, S, Tran, C, Jacques-Palaz, KD, Miller, WR & Arias, CA 2023, , 6th Annual Texas Medical Center Antimicrobial Resistance and Stewardship Conference, January 18-20, 2023, Houston, United States, 1/18/23 - 1/20/23.

A Case of successful treatment of recurrent urinary tract infection by extended-spectrum ß-lactamase producing klebsiella pneumoniae using oral lyophilized fecal microbiota transplant
Bier, N, Hanson, B, Jiang, ZD, Dupont, HL, Arias, CA & Miller, WR 2023, , Microbial Drug Resistance, vol. 29, no. 1, pp. 34-38. https://doi.org/10.1089/mdr.2022.0031

Optimization of a Nitrocefin-Based Rapid Test for the Detection of the Cefazolin Inoculum Effect (CzIE) in MSSA
Villegas, SG, Panesso, D, Singh, KV, Rincon, S, Carvajal, LP, Jacques-Palaz, KD, Rizvi, S, Reyes, MI, Abbott, A, Burnham, CAD, Bard, JD, Westblade, LF, Fritz, S, Zimmer, B, Dingle, TC, Butler-Wu, S, Miller, WR, Reyes, J & Arias, CA 2023, , IDWeek 2023 , Boston, United States, 10/11/23 - 10/15/23.

LiaX is a surrogate marker for cell-envelope stress and daptomycin non-susceptibility in Enterococcus faecium
Axell-House, DB, Simmar, S, Rincon, S, Miller, WR, Khan, A, Pemberton, O, Valdez, L, Nguyen, A, Hood, KS, Rydell, K, DeTranaltes, AM, Jones, MN, Atterstrom, R, Reyes, J, Sahasrabhojane, P, Suleyman, G, Zervos, MJ, Shelburne, SA, Singh, KV, Shamoo, Y, Hanson, BM, Tran, C & Arias, CA 2023, , bioRxiv.

The enterococci
Nguyen, AH, Axell-House, DB, Miller, WR & Arias, CA 2023, . in Molecular Medical Microbiology, Third Edition. Elsevier, pp. 755-774. https://doi.org/10.1016/B978-0-12-818619-0.00046-0

Human Dectin-1 deficiency impairs macrophage-mediated defense against phaeohyphomycosis
Drummond, RA, Desai, JV, Hsu, AP, Oikonomou, V, Vinh, DC, Acklin, JA, Abers, MS, Walkiewicz, MA, Anzick, SL, Swamydas, M, Vautier, S, Natarajan, M, Oler, AJ, Yamanaka, D, Mayer-Barber, KD, Iwakura, Y, Bianchi, D, Driscoll, B, Hauck, K, Kline, A, Viall, NSP, Zerbe, CS, Ferré, EMN, Schmitt, MM, DiMaggio, T, Pittaluga, S, Butman, JA, Zelazny, AM, Shea, YR, Arias, CA, Ashbaugh, C, Mahmood, M, Temesgen, Z, Theofiles, AG, Nigo, M, Moudgal, V, Bloch, KC, Kelly, SG, Suzanne Whitworth, M, Rao, G, Whitener, CJ, Mafi, N, Gea-Banacloche, J, Kenyon, LC, Miller, WR, Boggian, K, Gilbert, A, Sincock, M, Freeman, AF, Bennett, JE, Hasbun, R, Mikelis, CM, Kwon-Chung, KJ, Belkaid, Y, Brown, GD, Lim, JK, Kuhns, DB, Holland, SM & Lionakis, MS 2022, , Journal of Clinical Investigation, vol. 132, no. 22, e159348. https://doi.org/10.1172/JCI159348

Bacterial cell membranes and their role in daptomycin resistance: A review
Nguyen, AH, Hood, K, Mileykovskaya, E, Miller, WR & Tran, C 2022, , Frontiers in Molecular Biosciences, pp. 1035574. https://doi.org/10.3389/fmolb.2022.1035574

Bacterial cell membranes and their role in daptomycin resistance: A review
Nguyen, AH, Hood, KS, Mileykovskaya, E, Miller, WR & Tran, TT 2022, , Frontiers in Molecular Biosciences, vol. 9, 1035574. https://doi.org/10.3389/fmolb.2022.1035574